Abbott Laboratories
NYSE: ABT
$117.96
-$0.17 (-0.1%)
Closing Price on November 26, 2024
ABT Articles
Thursday after the close, we’ll get to see earnings out of Genentech (NASDAQ: DNA). The estimates from First Call are $0.82 EPS on $3.11 billion in revenues. Next quarter estimates are $0.86 EPS...
Published:
These are the top analyst calls we are focusing on early this Thursday morning in pre-market trading: Abbott Laboratories (NYSE: ABT) Raised To Outperform at Wachovia. Altria (NYSE: MO) started as...
Published:
Medtronic, Inc. (NYSE: MDT) has just announced that it has received formal approval from the FDA to market its Endeavor Zotarolimus-Eluting Coronary Stent System for the treatment of coronary artery...
Published:
We are full fledged into earnings season now, so most news coverage will point to the current earnings environment and guidance. There are of course drug developments and other contracts awards. ...
Published:
James Tobin, the CEO of Boston Scientific (NYSE:BSX) is likely to find himself in front of the shareholder firing squad in 2008. In early 2004 this stock was above $40 and had enjoyed an incredible...
Published:
Last Updated:
Abbott Labs (ABT) which just launched a new stent product, Xience V, has laid off 1,200 people because of slowness in the stent market. Stranger than fiction. According to MarketWatch, Abbott says it...
Published:
According to Reuters, Fed chief Bernanke said the resurgence in financial strains in recent weeks had dimmed the outlook for the U.S. economy. Reuters writes that Dell’s (DELL) profit rose but if...
Published:
Abbot Labs (ABT) is trying to get into the stent business. The market has been dominated by Boston Scientific (BSX) and Johnson & Johnson (JNJ). Stents are small mess implants which are designed...
Published:
Boston Scientific (BSX) has been the leader in sales of stents, those little mess tubes that keep arteries open. Recent studies show that the devices are more dangerous than most doctors had...
Published:
(ABT) Abbott Labs $0.69 EPS vs $0.68 estimate; guidance looks soft.(ASD) American Standard $0.84 EPS net, but $1.05 before items; estimates were $1.08. Spin-off/sale remains on track. (BLK) Blackrock...
Published:
MONDAYMattel (NYSE:MAT)Novellus (NASDAQ:NVLS)Philips Electronics (NYSE:PHG/ADR)W.W. Grainger (NYSE:GWW) TUESDAYJohnson & Johnson (NYSE:JNJ)Intel Corporation (NASDAQ: INTC)Merrill Lynch...
Published:
GE’s (GE) share price has had a bit of a run over the last three months. Until that point, the stock was flat with where it traded in July 2005. Now, two years later, the shares are up 10%. Over...
Published:
According to Reuters, Rio Tinto (RTP) has launched a $38.1 billion takeover bid for Alcan (AL). Reuters writes that customers at JP Morgan have been confused by opposite calls on future plans for...
Published:
As you will see, the short interest changes in medical and drug stocks of the active NYSE-listed names was a bit of a mixed bag. GlaxoSmithkline (GSK) saw the lagest increase, but its short...
Published:
This weekend we have the mother of all future cancer treatment conferences: ASCO, or The American Society of Clinical Oncology. Cancer stocks in the last few weeks have been seeing a muted response...
Published: